The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Bio Reference Lab Inc

  • BRLI
  • NASDAQ
  • Consumer Products
  • Latest 27.20
  • Currency US$
  • Change -0.19
  • Percent Change -0.694 %
  • Volume 167,137
  • Thu Apr 17, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
Average recommendation
2 Analysts Reporting (Apr 17, 2014)
Strong Buy
Buy
Hold
Underperform
Sell
Change over time
Analyst rating breakdown
  Latest 4 weeks ago 2 months ago 3 months ago Last Year
Strong Buy 1 1 1 1 3
Buy 0 0 0 0 0
Hold 1 1 1 1 0
Underperform 0 0 0 0 0
Sell 0 0 0 1 1

As of Sun Apr 20, 2014 1:12 PM EDT
The consensus recommendation is the average buy, sell or hold rating for a company, based on a survey of brokerage equity analysts by Zacks Investment Research. We update the ratings daily.

Earnings & Estimates

Short Term
    Q1/12 Q2/12 Q3/12 Q4/12 Q2/13 Q3/13 Q4/13 Q1/14 Q2/14 Q3/14  

Actual quarterly earnings for the past eight quarters and estimated for the next two quarters

Estimated EPS ($)   0.21 0.32 0.42 0.46 0.40 0.52 0.40 0.14 0.33 0.54  
Actual EPS   0.26 0.33 0.45 0.46 0.41 0.53 0.40 0.11 -- --  
Surprise (%)   23.8 3.1 7.1 -- 2.5 1.9 -- -21.4 -- --  
Est. % Chg from Prior Year   0.5 -0.2 0.2 0.2 0.2 0.2 -0.1 -- -19.5 1.9  
{#} Analysts   4 5 5 4 3 3 3 2 2 1  
Date of Earnings   Mar 01 Jun 07 Aug 30 Dec 06 Jun 06 Aug 29 Dec 19 Mar 04 Jun 05 Sep 04  

Data provided by Zacks Investment Research.

Long Term
    2014 2015  

Estimated annual earnings for the next
two years

Estimated EPS ($)   1.67 1.94  
Actual EPS   1.65 1.67  
Surprise (%)   -- --  
Est. % Chg from Prior Year   1.2 15.9  
{#} Analysts   2 2  
Date of Earnings   -- --  

Trends & Revisions

Earnings Per Share Trend
  Current 7-Days Ago 30-Days Ago 60-Days Ago 90-Days Ago
  Mean Mean Mean Mean Mean
Current Quarter (ends Apr 2014) 0.33 0.33 0.33 0.42 0.43
Next Quarter (ends Jul 2014) 0.54 0.54 0.54 0.56 0.56
Current Fiscal Year (ends Oct 2014) 1.67 1.67 1.67 1.76 1.79
Next Fiscal Year (ends Oct 2015) 1.94 1.94 1.94 2.00 2.02

Data provided by Zacks Investment Research.

Earnings Revisions
Last 7 Days Last 30 Days
Up Revs Down Revs Up Revs Down Revs
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0